• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist


1.040 EUR 0.001 0.10%

As of 04:55:03 ET on 07/24/2014.

Snapshot for Dynavax Technologies Corp (DYF)

Open: 1.041 Day's Range: 1.040 - 1.050 Volume: 0
Previous Close: 1.039 52wk Range: 0.800 - 1.548 1-Yr Rtn: +11.47%

Stock Chart for DYF

No chart data available.
  • DYF:GR 1.040
  • 1D
  • 1M
  • 1Y
Interactive DYF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2500
Est. PEG Ratio -
Market Cap (M EUR) 273.37
Shares Outstanding (M) 262.86
30 Day Average Volume 587
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYF

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Eddie GrayChief Executive OfficerRobert Lee CoffmanSenior VP/Chief Scientific
David L JohnsonVP/Chief Acctg OfficerMichael S OstrachVP/Chief Bus Ofcr/Secy/Gen Cnsl
More Company Profile & Key Executives for DYF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil